Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones

L van de Corput1, H C Kluin-Nelemans, M G Kester

  • 1Laboratory of Experimental Hematology, Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Blood
|December 24, 1998
PubMed

Insights

Researchers identified specific T-cell clones that recognize hairy cell leukemia (HCL) cells. These HCL-specific T-cells offer potential for detecting a tumor antigen in hairy cell leukemia patients.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Hairy cell leukemia (HCL) is a rare B-cell malignancy.
  • The role of T-cell immunity in HCL pathogenesis is not fully understood.
  • Identifying tumor-specific T-cell responses can aid in diagnostics and therapeutics.

Purpose of the Study:

  • To investigate the presence and characteristics of autoreactive T cells specific to HCL cells.
  • To determine if these T cells can be utilized for HCL detection.

Main Methods:

  • HCL cells were activated via CD40 triggering and used to generate autologous T-cell clones.
  • T-cell clone reactivity was assessed against autologous HCL cells, peripheral blood mononuclear cells (PBMC), and other cell types using a primed lymphocyte test.
  • HLA restriction of T-cell recognition was analyzed through blocking and panel studies.

Main Results:

  • Two types of CD4(+)BV2(+) T-cell clones and one CD4(+)BV8S3(+) T-cell clone specifically recognized autologous HCL cells.
  • These T-cell clones did not react to autologous non-leukemic cells or other hematologic malignancies.
  • BV2(+) T-cell recognition was restricted by HLA-DQA1*03/DQB1*0301, and BV8S3(+) T-cell recognition by DPB1*04.

Conclusions:

  • Autoreactive T-cell clones with specific reactivity against HCL cells were successfully generated.
  • These HCL-specific T-cell clones demonstrate potential as diagnostic tools for detecting HCL-specific tumor antigens.